Ghrelin Levels in Early IVF Pregnancies

This study has been completed.
Sponsor:
Information provided by:
Instituto Valenciano de Infertilidad, IVI VALENCIA
ClinicalTrials.gov Identifier:
NCT00469807
First received: May 3, 2007
Last updated: May 4, 2007
Last verified: May 2007
  Purpose

In this study, we have assessed the potential prognostic value for gestational outcome of maternal ghrelin levels at very early stages of IVF pregnancies. In addition, ghrelin responses to meal intake were explored at early gestation.


Condition
Pregnancy

Study Type: Observational
Study Design: Time Perspective: Longitudinal
Official Title: Maternal Serum Ghrelin Levels in Early IVF Pregnancies: Lack of Prognostic Value for Gestational Outcome and Altered Post-Prandial Responses

Further study details as provided by Instituto Valenciano de Infertilidad, IVI VALENCIA:

Study Start Date: June 2004
Study Completion Date: May 2007
Detailed Description:

Ghrelin is a pleiotropic hormone recently involved in the control of growthand metabolism, whose circulating levels fluctuate in relation to food intake and body mass index. Ghrelin has been detected in the decidualized endometrium, as well as in human and rat placenta, with a distinctive temporal pattern of expression along pregnancy.

Comparison(s): A total of 106 patients undergoing IVF procedures were prospectively recruited. On d-16 and 23 after oocyte retrieval, the patients were subjected to blood sampling after overnight fasting, for determination of serum ghrelin, hCG and progesterone levels. In addition, ghrelin levels were assayed in these groups, 2-h after ingestion of a fixed-calorie meal.

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients undergoing IVF
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00469807

Locations
Spain
Ivi Valencia
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, IVI VALENCIA
Investigators
Study Chair: Antonio Pellicer, MD Instituto Valenciano de Infertilidad
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00469807     History of Changes
Other Study ID Numbers: VLC-CV-0604-507-22
Study First Received: May 3, 2007
Last Updated: May 4, 2007
Health Authority: Spain: Comité Ético de Investigación Clínica

Keywords provided by Instituto Valenciano de Infertilidad, IVI VALENCIA:
Ghrelin
Pregnancy outcome

ClinicalTrials.gov processed this record on July 28, 2014